Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose IV Casopitant for Prevention of Oxaliplatin-Induced Nausea and Vomiting
NCT00601172Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of casopitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by GSK. Started Mar 2008; status: completed.
02
Drugs
casopitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00601172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601172.